Combination of isothiocyanates and antibiotics increases susceptibility against Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens.

Ngalah, Bidii Stephen; Börner, Katharina; Kropidlowsky, Moritz; Finkbeiner, Johanna; Harter, Alexander; Biehler, Klaus; Frank, Uwe

Ngalah, Bidii Stephen; Börner, Katharina; Kropidlowsky, Moritz; Finkbeiner, Johanna; Harter, Alexander; Biehler, Klaus; Frank, Uwe.

Afiliación

Ngalah BS; BioPhytoMedical Drug Discovery and Development, Freiburg im Breisgau, Germany; Medical Faculty, University of Heidelberg, Heidelberg, Germany.
Börner K; BioPhytoMedical Drug Discovery and Development, Freiburg im Breisgau, Germany.
Kropidlowsky M; BioPhytoMedical Drug Discovery and Development, Freiburg im Breisgau, Germany.
Finkbeiner J; BioPhytoMedical Drug Discovery and Development, Freiburg im Breisgau, Germany.
Harter A; BioPhytoMedical Drug Discovery and Development, Freiburg im Breisgau, Germany.
Biehler K; BioPhytoMedical Drug Discovery and Development, Freiburg im Breisgau, Germany.
Frank U; BioPhytoMedical Drug Discovery and Development, Freiburg im Breisgau, Germany. Electronic address: biophyto@gmx.com.

Fitoterapia ; : 105382, 2022 Nov 30.

Article en En | MEDLINE | ID: mdl-36462662

Palabras clave

A. baumannii; Antimicrobial activity; Fractional inhibitory concentration index (FIC); Isothiocyanates; K. pneumoniae; P. mirabilis; S. marcescens

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Fitoterapia Año: 2022 Tipo del documento: Article País de afiliación: Alemania